- PVLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
Palvella Therapeutics (PVLA) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
13F-HR/A
|
Morgan Stanley | 76.00 | 14 Feb 25 | 30 Sep 24 | 756.00 | -90% | 31 Mar 24 |
SC 13G
|
Frazier Life Sciences Public Fund, L.P | 440.58 k | 8 Jan 25 | 13 Dec 24 | 0.00 | +∞% | - |
13F-HR/A
|
JPMorgan Chase & Co. | 23.00 | 26 Dec 24 | 30 Sep 24 | 24.00 | -4% | 30 Jun 24 |
13F-HR/A
|
JPMorgan Chase & Co. | 24.00 | 26 Dec 24 | 30 Jun 24 | 1.82 k | -99% | 31 Mar 24 |
13F-HR/A
|
JPMorgan Chase & Co. | 1.82 k | 26 Dec 24 | 31 Mar 24 | 1.80 k | +1% | 31 Dec 23 |
13F-HR/A
|
JPMorgan Chase & Co. | 1.80 k | 26 Dec 24 | 31 Dec 23 | 112.12 k | -98% | 30 Sep 23 |
SC 13D
|
Wesley H. Kaupinen 2019 Irrevocable Trust dated February 28, 2019 | 781.41 k | 20 Dec 24 | 13 Dec 24 | 0.00 | +∞% | - |
SC 13G
|
Samsara BioCapital, L.P | 679.49 k | 20 Dec 24 | 13 Dec 24 | 0.00 | +∞% | - |
SC 13G
|
SUVRETTA CAPITAL MANAGEMENT | 714.46 k | 20 Dec 24 | 13 Dec 24 | 0.00 | +∞% | 30 Sep 24 |
SC 13G/A
|
BVF Partners L.P | 1.17 mm | 17 Dec 24 | 13 Dec 24 | 257.62 k | +353% | 15 May 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.